Skip to content

Depression: all studies

Page 299 of 1,034: studies 2,981 to 2,990 of 10,336, newest first. Back to the depression overview

Research

Mindfulness-based cognitive therapy for depression: trends and developments.

Psychology Research and Behavior Management 2016 Meagan B. MacKenzie, Nancy L. Kocovski

Mindfulness-based cognitive therapy (MBCT) was developed as a psychological intervention for individuals at risk of depressive relapse. Possible mechanisms of change for this intervention are in line with its theoretical underpinnings, and include increases in mindfulness and/or decreases in negative repetitive thoughts. This review provides an overview of current trends in MBCT research,...

DOI: 10.2147/prbm.s63949 (opens in new tab) Full text (opens in new tab) Mbct Dissemination Efficacy Mechanisms of change +1

Mindfulness-based cognitive therapy in patients with late-life depression: A case series.

International Journal of Yoga 2016 Sonal Mathur, Mahendra Prakash Sharma, Srikala Bharath

Depression is the most common mental illness in the elderly, and cost-effective treatments are required. Therefore, this study is aimed at evaluating the effectiveness of a mindfulness-based cognitive therapy (MBCT) on depressive symptoms, mindfulness skills, acceptance, and quality of life across four domains in patients with late-onset depression. A single case design with pre- and...

Manual Development and Pilot Randomised Controlled Trial of Mindfulness-Based Cognitive Therapy Versus Usual Care for Parents with a History of Depression.

Mindfulness 2016 Joanna Mann, Willem Kuyken, Heather O'Mahen et al.

Parental depression can adversely affect parenting and children's development. We adapted mindfulness-based cognitive therapy (MBCT) for parents (MBCT-P) with a history of depression and describe its development, feasibility, acceptability and preliminary estimates of efficacy. Manual development involved interviews with 12 parents who participated in MBCT groups or pilot MBCT-P groups. We...

DOI: 10.1007/s12671-016-0543-7 (opens in new tab) Full text (opens in new tab) Depression Children’s behaviour Mindfulness-based cognitive therapy Parenting +1

Effects of ketamine on depression beneficial but short‐term

The Brown University Psychopharmacology Update 2016

A review and meta‐analysis of the effects of N‐methyl‐D‐aspartate (NMDA) receptor antagonists in treating major depression has confirmed that ketamine is the only such drug to date that has demonstrated antidepressant efficacy across multiple trials. Authors of the review stated, however, that the findings regarding ketamine should be viewed with caution because the beneficial effects are not...

Ketamine modulates subgenual cingulate connectivity with the memory-related neural circuit-a mechanism of relevance to resistant depression?

PeerJ 2016 Jing J Wong, Owen O'Daly, Mitul A. Mehta et al.

Background. Ketamine has been reported to have efficacy as an antidepressant in several studies of treatment-resistant depression. In this study, we investigate whether an acute administration of ketamine leads to reductions in the functional connectivity of subgenual anterior cingulate cortex (sgACC) with other brain regions. Methods. Thirteen right-handed healthy male subjects underwent a 15...

Sarah Kane's world of depression : the emergence and experience of mental illness in 4.48 psychosis

University writing server of the Justus Liebig University Giessen 2016 Anna Ovaska, Justus Liebig University Giessen 3 citations

Fictional narratives of mental illnesses often focus on individual experiences of pain, anxiety and suffering. As such, narratives depict the experiences of illness in a holistic way, revealing the embodied, situated and intersubjective in other words, emer-gent nature of psychiatric disorders. They are thus able to create a different kind of understanding of mental disorders than medicalizing...

The Effects of Mindfulness-Based Cognitive Therapy on Depression and Anxiety in Women with Premenstrual Syndrome

Depression Research and Treatment 2016 Faeze Panahi, Mahbobeh Faramarzi

Objective. Little research has been done regarding the role of psychotherapy in the treatment of Premenstrual Syndrome (PMS). The aim of this study was to examine the effect of mindfulness-based cognitive therapy (MBCT) on the PMS symptoms and depression and anxiety symptoms in women with PMS. Design. In a randomized controlled trial, a total of 60 students at Mazandaran University with mild to...

A Randomized Controlled Trial of Mindfulness-Based Cognitive Therapy for Treatment-Resistant Depression

Psychotherapy and Psychosomatics 2016 Stuart J. Eisendrath, Erin P Gillung, Kevin L. Delucchi et al. 193 citations

BACKGROUND: Due to the clinical challenges of treatment-resistant depression (TRD), we evaluated the efficacy of mindfulness-based cognitive therapy (MBCT) relative to a structurally equivalent active comparison condition as adjuncts to treatment-as-usual (TAU) pharmacotherapy in TRD. METHODS: This single-site, randomized controlled trial compared 8-week courses of MBCT and the Health...

Effects of a 12-Week Mindfulness, Compassion, and Loving Kindness Program on Chronic Depression: A Pilot Within-Subjects Wait-List Controlled Trial.

Journal of Cognitive Psychotherapy 2016 Johannes Graser, Volkmar Höfling, Charlotte Weβlau et al.

In this pilot study, N = 11 patients suffering from chronic depression were treated in a 12-week group program consisting of basic mindfulness exercises from Mindfulness-Based Cognitive Therapy and compassion exercises from Compassion Focused Therapy and Loving Kindness Meditation. In a 3-month waiting period prior to treatment, depression symptoms both in self-report and clinician rating did...

Kappa Opioids, Salvinorin A and Major Depressive Disorder.

Current Neuropharmacology 2016 George T Taylor, Francesca Manzella

Opioids are traditionally associated with pain, analgesia and drug abuse. It is now clear, however, that the opioids are central players in mood. The implications for mood disorders, particularly clinical depression, suggest a paradigm shift from the monoamine neurotransmitters to the opioids either alone or in interaction with monoamine neurons. We have a special interest in dynorphin, the...